Phio Pharmaceuticals Corp.

PHIO

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001533040

SEC filings (opens in a new tab)

In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Phio Pharmaceuticals Corp. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of PHIO: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	13	15	+2
Shares	779.5K	727.7K	−51.8K (−6.6%)
Value	$551.0K	$415.0K	−$136.0K (−24.7%)

New holders (3)

Institutions that held Phio Pharmaceuticals Corp. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to PHIO in Q3 2022
Institution	Shares	Value	% of portfolio
HRT Financial LP	18,280	$10.0K	0.00%
Ergoteles LLC	12,471	$7.00K	0.00%
Balyasny Asset Management LLC	10,036	$6.00K	0.00%

Sold out (1)

Institutions that held Phio Pharmaceuticals Corp. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of PHIO in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Simplex Trading, LLC	398	$0